M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Salix Pharmaceuticals Ltd announces receipt of US Patent for rifaximin
Salix Pharmaceuticals Ltd (NASDAQ:SLXP), a developer and marketer of prescription pharmaceutical products for the treatment of gastrointestinal diseases, declared on 18 November the grant of US Patent No. 7,452,857 from the United States Patent and Trademark Office.
Â
The company stated...
If you want to view the full text of this story, you must first purchase archive retrieval credits.